Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs

Chunfeng D Zhao, Yasuhiro Ozasa, Haruhiko Shimura, Ramona L. Reisdorf, Andrew R. Thoreson, Gregory Jay, Steven Lawrence Moran, Kai Nan An, Peter C Amadio

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model. Seventy-eight flexor tendons from 39 dogs were transected. One tendon was treated with cd-HA-lubricin plus an interpositional graft of 8 × 105 BMSCs and GDF-5. The other tendon was repaired without treatment. After 21 day of immobilization, 19 dogs were sacrificed; the remaining 20 dogs underwent a 21-day rehabilitation protocol before euthanasia. The work of flexion, tendon gliding resistance, and adhesion score in treated tendons were significantly less than the untreated tendons (p <0.05). The failure strength of the untreated tendons was higher than the treated tendons at 21 and 42 days (p <0.05). However, there is no significant difference in stiffness between two groups at day 42. Histologic analysis of treated tendons showed a smooth surface and viable transplanted cells 42 days after the repair, whereas untreated tendons showed severe adhesion formation around the repair site. The combination of lubricant and cell treatment resulted in significantly improved digit function, reduced adhesion formation. This novel treatment can address the unmet needs of patients who are unable to commence an early mobilization protocol after flexor tendon repair.

Original languageEnglish (US)
Pages (from-to)154-160
Number of pages7
JournalJournal of Orthopaedic Research
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Lubricants
Mesenchymal Stromal Cells
Tendons
Carbodiimides
Dogs
Hyaluronic Acid
Growth Differentiation Factor 5
Early Ambulation
Euthanasia
Therapeutics
Cell- and Tissue-Based Therapy
Immobilization
Canidae
Rehabilitation

Keywords

  • bone marrow stromal cells
  • flexor tendon
  • hyaluronic acid
  • immobilization
  • lubricin
  • tendon repair

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs. / Zhao, Chunfeng D; Ozasa, Yasuhiro; Shimura, Haruhiko; Reisdorf, Ramona L.; Thoreson, Andrew R.; Jay, Gregory; Moran, Steven Lawrence; An, Kai Nan; Amadio, Peter C.

In: Journal of Orthopaedic Research, Vol. 34, No. 1, 01.01.2016, p. 154-160.

Research output: Contribution to journalArticle

Zhao, Chunfeng D ; Ozasa, Yasuhiro ; Shimura, Haruhiko ; Reisdorf, Ramona L. ; Thoreson, Andrew R. ; Jay, Gregory ; Moran, Steven Lawrence ; An, Kai Nan ; Amadio, Peter C. / Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs. In: Journal of Orthopaedic Research. 2016 ; Vol. 34, No. 1. pp. 154-160.
@article{defcaf7ec3f9473b81025de2078c3191,
title = "Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs",
abstract = "The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model. Seventy-eight flexor tendons from 39 dogs were transected. One tendon was treated with cd-HA-lubricin plus an interpositional graft of 8 × 105 BMSCs and GDF-5. The other tendon was repaired without treatment. After 21 day of immobilization, 19 dogs were sacrificed; the remaining 20 dogs underwent a 21-day rehabilitation protocol before euthanasia. The work of flexion, tendon gliding resistance, and adhesion score in treated tendons were significantly less than the untreated tendons (p <0.05). The failure strength of the untreated tendons was higher than the treated tendons at 21 and 42 days (p <0.05). However, there is no significant difference in stiffness between two groups at day 42. Histologic analysis of treated tendons showed a smooth surface and viable transplanted cells 42 days after the repair, whereas untreated tendons showed severe adhesion formation around the repair site. The combination of lubricant and cell treatment resulted in significantly improved digit function, reduced adhesion formation. This novel treatment can address the unmet needs of patients who are unable to commence an early mobilization protocol after flexor tendon repair.",
keywords = "bone marrow stromal cells, flexor tendon, hyaluronic acid, immobilization, lubricin, tendon repair",
author = "Zhao, {Chunfeng D} and Yasuhiro Ozasa and Haruhiko Shimura and Reisdorf, {Ramona L.} and Thoreson, {Andrew R.} and Gregory Jay and Moran, {Steven Lawrence} and An, {Kai Nan} and Amadio, {Peter C}",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/jor.22980",
language = "English (US)",
volume = "34",
pages = "154--160",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of lubricant and autologous bone marrow stromal cell augmentation on immobilized flexor tendon repairs

AU - Zhao, Chunfeng D

AU - Ozasa, Yasuhiro

AU - Shimura, Haruhiko

AU - Reisdorf, Ramona L.

AU - Thoreson, Andrew R.

AU - Jay, Gregory

AU - Moran, Steven Lawrence

AU - An, Kai Nan

AU - Amadio, Peter C

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model. Seventy-eight flexor tendons from 39 dogs were transected. One tendon was treated with cd-HA-lubricin plus an interpositional graft of 8 × 105 BMSCs and GDF-5. The other tendon was repaired without treatment. After 21 day of immobilization, 19 dogs were sacrificed; the remaining 20 dogs underwent a 21-day rehabilitation protocol before euthanasia. The work of flexion, tendon gliding resistance, and adhesion score in treated tendons were significantly less than the untreated tendons (p <0.05). The failure strength of the untreated tendons was higher than the treated tendons at 21 and 42 days (p <0.05). However, there is no significant difference in stiffness between two groups at day 42. Histologic analysis of treated tendons showed a smooth surface and viable transplanted cells 42 days after the repair, whereas untreated tendons showed severe adhesion formation around the repair site. The combination of lubricant and cell treatment resulted in significantly improved digit function, reduced adhesion formation. This novel treatment can address the unmet needs of patients who are unable to commence an early mobilization protocol after flexor tendon repair.

AB - The purpose of the study was to test a novel treatment that carbodiimide-derivatized-hyaluronic acid-lubricin (cd-HA-lubricin) combined cell-based therapy in an immobilized flexor tendon repair in a canine model. Seventy-eight flexor tendons from 39 dogs were transected. One tendon was treated with cd-HA-lubricin plus an interpositional graft of 8 × 105 BMSCs and GDF-5. The other tendon was repaired without treatment. After 21 day of immobilization, 19 dogs were sacrificed; the remaining 20 dogs underwent a 21-day rehabilitation protocol before euthanasia. The work of flexion, tendon gliding resistance, and adhesion score in treated tendons were significantly less than the untreated tendons (p <0.05). The failure strength of the untreated tendons was higher than the treated tendons at 21 and 42 days (p <0.05). However, there is no significant difference in stiffness between two groups at day 42. Histologic analysis of treated tendons showed a smooth surface and viable transplanted cells 42 days after the repair, whereas untreated tendons showed severe adhesion formation around the repair site. The combination of lubricant and cell treatment resulted in significantly improved digit function, reduced adhesion formation. This novel treatment can address the unmet needs of patients who are unable to commence an early mobilization protocol after flexor tendon repair.

KW - bone marrow stromal cells

KW - flexor tendon

KW - hyaluronic acid

KW - immobilization

KW - lubricin

KW - tendon repair

UR - http://www.scopus.com/inward/record.url?scp=84954053212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954053212&partnerID=8YFLogxK

U2 - 10.1002/jor.22980

DO - 10.1002/jor.22980

M3 - Article

C2 - 26177854

AN - SCOPUS:84954053212

VL - 34

SP - 154

EP - 160

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 1

ER -